Dopamine Transporter Internalization
Dopamine Transporter Internalization - Related Videos
05:01
Measuring Dopamine Uptake in Mouse Brain Synaptosomes Using Radiolabeled Dopamine
0 Views •
2025
This video demonstrates the assessment of dopamine uptake in synaptosomes harvested from mouse brains. It outlines steps for preparing synaptosomes for dopamine uptake via dopamine transporters, treating them with varying concentrations of radiolabeled dopamine, isolating the synaptosomes, and measuring radioactivity to quantify dopamine uptake.
07:30
Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
0 Views •
Cited by 1 •
2012
The amperometric technique measures dopamine release from a single cell by detecting the oxidative current produced by spontaneous dopamine oxidization. Simultaneous voltage clamp and amperometry methodology reveal the mechanistic relationship between the overall "activity" of dopamine transporter and the regulatory role of this activity on the reverse transport of dopamine.
02:09
Monitoring Dopamine Release in a Rat Model with VTA Dopaminergic Neuron Receptor Manipulation
0 Views •
2025
This video demonstrates the implantation of electrodes and cannulas in an anesthetized rat to measure dopamine release in the nucleus accumbens using a potentiostat and the infusion of drugs to modulate dopaminergic activity in the ventral tegmental area.
02:11
Formulating a Dopamine-Loaded Exosome Carrier System
0 Views •
2025
Source: Yavuz, B., et al. Formulating and Characterizing an Exosome-based Dopamine Carrier System. J. Vis. Exp. (2022)This video demonstrates the formulation of dopamine-loaded exosomes, focusing on saponin-induced membrane permeabilization to enhance dopamine encapsulation within exosomes.
08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
0 Views •
Cited by 57 •
2010
Parkinson disease is caused by loss of dopaminergic innervation to the striatum, which can be experimentally induced by 6-OH-dopamine. We describe how to perform a stereotaxic lesion and to monitor apomorphine-induced rotational behavior in mice. This model is useful and reliable for testing new therapies for Parkinson disease.
FAQs
Phosphorylation provides a regulatory step that can accompany redistribution of dopamine transporter proteins away from the plasma membrane. By changing the transporter’s cellular handling, this modification may promote movement through endocytic pathways and reduce the amount of transporter available at the neuronal surface. Its importance lies in linking intracellular signaling with changes in dopamine clearance.
Exposure to transporter ligands can act as a signal associated with dopamine transporter redistribution from the cell surface into intracellular vesicles. This response changes transporter availability without requiring immediate removal of the protein from the cell. Studying ligand-dependent trafficking helps clarify how chemical interactions with DAT can alter dopamine reuptake and synaptic signaling.
Dopamine reuptake depends on transporter proteins positioned at the neuronal plasma membrane. When DAT is redistributed into intracellular vesicles through endocytic pathways, fewer transporters remain available at that surface location. The resulting reduction in transporter access can decrease dopamine clearance from the synaptic space, thereby changing the strength and duration of dopamine signaling.
The process gives neurons a way to adjust transporter availability in response to cellular signals or ligand exposure. Rather than maintaining a fixed surface level of DAT, the cell can redistribute transporter proteins and modify dopamine clearance over time. This provides a mechanism for regulating signaling strength as neuronal conditions change, although the overview does not specify the duration or reversibility of each response.
A focused investigation can follow the relationship between cellular signals or transporter-ligand exposure, DAT phosphorylation, redistribution into intracellular vesicles, and reduced surface availability. These events connect molecular regulation to a functional outcome, namely altered dopamine reuptake. Organizing the study around this sequence helps distinguish initiating signals from trafficking changes and their effects on dopamine clearance.
Psychostimulant action is one reason researchers examine how transporter proteins move between the cell surface and intracellular compartments. Ligand-associated changes in DAT localization can influence how efficiently neurons clear dopamine, providing context for altered dopaminergic signaling. This makes transporter trafficking a useful biological framework for studying how psychostimulants affect dopamine transmission beyond a static view of transporter abundance.
Disorders involving dopamine imbalance may be studied by asking whether changes in transporter trafficking contribute to abnormal dopamine clearance or signaling strength. Understanding phosphorylation, endocytic redistribution, and surface transporter availability can also guide therapeutic research aimed at modifying dopamine transmission. The mechanism therefore connects cellular regulation with disease-related questions and potential strategies that target DAT or its associated trafficking processes.